Efficacy and Safety of Surufatinib Combined With Gemcitabine and Albumin-bound Paclitaxel in the Peri-operative Treatment of Pancreatic Cancer
Clinical trial NCT05908747 · COMPLETED
Trial details
- NCT number
- NCT05908747
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-31
- Primary completion
- 2025-05-16
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.